Waters price to free cash flow WAT
Market value divided by free cash flow over the last twelve months, since 2010.
- Today, Oct 23, 2026
- 112×
- 10-year median
- 32.4×
- Against its 10-year history
- 97th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 21.2× to 151×
- Peer median
- 30.7×
Waters' price to free cash flow is 112× as of Oct 23, 2026.
That is above its ten-year median of 32.4×, higher than on 97% of days in the last ten years.
Over that time it ranged from 21.2× in Dec 2016 to 151× in Aug 2026.
The median for 10 diagnostics and research stocks of a similar size is 30.7×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 112× | 32.0× | 151× |
| 2025 | 38.2× | 27.0× | 39.9× |
| 2024 | 35.9× | 33.0× | 50.2× |
| 2023 | 49.9× | 34.4× | 50.0× |
| 2022 | 43.1× | 30.5× | 43.7× |
| 2021 | 35.9× | 26.8× | 40.0× |
| 2020 | 28.6× | 22.5× | 32.7× |
| 2019 | 30.7× | 26.2× | 35.5× |
| 2018 | 26.9× | 24.3× | 29.0× |
| 2017 | 25.6× | 22.1× | 27.4× |
| 2016 | 21.2× | 19.8× | 27.8× |
| 2015 | 23.1× | 20.7× | 25.4× |
| 2014 | 24.0× | 22.1× | 27.7× |
| 2013 | 24.3× | 20.9× | 26.1× |
| 2012 | 20.8× | 16.0× | 21.3× |
| 2011 | 16.0× | 15.5× | 23.3× |
| 2010 | 17.3× | 11.2× | 17.9× |
Against its peers
Companies in Medical - Diagnostics & Research nearest Waters' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| WATWaters | 112× |
| IDXXIDEXX Laboratories | 35.2× |
| IQVIQVIA | 21.1× |
| AAgilent Technologies | 38.5× |
| ILMNIllumina | 43.7× |
| MTDMettler-Toledo International | 38.7× |
| DGXQuest Diagnostics | 19.8× |
| LHLabcorp | 23.1× |
| MEDPMedpace | 26.4× |
| RVTYRevvity | 31.7× |
| DHRDanaher | 29.6× |
| Peer median | 30.7× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Waters
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.